Human bioengineered artery equivalents may represent a first step toward the future replacement of the animal models used for studying the initial phases of atherosclerosis
Get full access to this article
View all access options for this article.
References
1.
National Heart, Lung & Blood Institute (2012). NHLBI Fact Book, Fiscal Year 2012 — By Section, 201pp. Bethesda, MD, USA: National Institutes of Health, US Department of Health & Human Services. Available at: http://www.nhlbi.nih.gov/about/factbook/toc.htm (Accessed 25.05.14).
RobertJ., WeberB., FreseL., EmmertM.Y., SchmidtD., von EckardsteinA., RohrerL. & HoerstrupS.P. (2013). A three-dimensional engineered artery model for in vitro atherosclerosis research. PLoS One14, e79821.
5.
WilliamsK.J. & TabasI. (1998). The response-to-retention hypothesis of atherogenesis reinforced. Current Opinion in Lipidology9, 471–474.
6.
GlassC.K. & WitztumJ.L. (2001). Atherosclerosis: The road ahead. Cell104, 503–516.
7.
RosensonR.S., BrewerH.B.Jr, DavidsonW.S., FayadZ.A., FusterV., GoldsteinJ., HellersteinM., JiangX.C., PhillipsM.C., RaderD.J., RemaleyA.T., RothblatG.H., TallA.R. & Yvan-CharvetL. (2012). Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation125, 1905–1919.
8.
BrokoppC.E., SchoenauerR., RichardsP., BauerS., LohmannC., EmmertM.Y., WeberB., WinnikS., AikawaE., GravesK., GenoniM., VogtP., LüscherT.F., RennerC., HoerstrupS.P. & MatterC.M. (2011). Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. European Heart Journal32, 2713–2722.
9.
WhitmanS.C. (2004). A practical approach to using mice in atherosclerosis research. Clinical Biochemistry Reviews25, 81–93.
10.
XiangdongL., YuanwuL., HuaZ., LimingR., QiuyanL. & NingL. (2011). Animal models for the atherosclerosis research: A review. Protein Cell2, 189–201.
11.
HamamdzicD. & WilenskyR.L. (2013). Porcine models of accelerated coronary atherosclerosis: Role of diabetes mellitus and hypercholesterolemia. Journal of Diabetes Research2013, 761415. [doi: 10.1155/2013/761415]
12.
ChenZ., StrackA.M., StefanniA.C., ChenY., WuW., PanY., Urosevic-PriceO., WangL., McLaughlinT., GeoghagenN., LassmanM.E., RoddyT.P., WongK.K., HubbardB.K. & FlatteryA.M. (2011). Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research. Journal of Cardiovascular Translational Research4, 373–383.
13.
RaynerK.J., EsauC.C., HussainF.N., McDanielA.L., MarshallS.M., van GilsJ.M., RayT.D., SheedyF.J., GoedekeL., LiuX., KhatsenkoO.G., KaimalV., LeesC.J., Fernandez-HernandoC., FisherE.A., TemelR.E. & MooreK.J. (2011). Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, London478, 404–407.
14.
YinW., Carballo-JaneE., McLarenD.G., MendozaV.H., GagenK., GeoghagenN.S., McNamaraL.A., GorskiJ.N., EiermannG.J., PetrovA., WolffM., TongX., WilsieL.C., AkiyamaT.E., ChenJ., ThankappanA., XueJ., PingX., AndrewsG., WickhamL.A., GaiC.L., TrinhT., KulickA.A., DonnellyM.J., VoroninG.O., RosaR., CumiskeyA.M., BekkariK., MitnaulL.J., PuigO., ChenF., RaubertasR., WongP.H., HansenB.C., KoblanK.S., RoddyT.P., HubbardB.K. & StrackA.M. (2012). Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. Journal of Lipid Research53, 51–65.
RobertJ., WeberB., FreseL., EmmertM.Y., SchmidtD., von EckardsteinA., RohrerL. & HoerstrupS.P. (2013). A three-dimensional engineered artery model for in vitro atherosclerosis research. PLoS One8, e79821.
NavabM., HoughG.P., StevensonL.W., DrinkwaterD.C., LaksH. & FogelmanA.M. (1988). Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. The Journal of Clinical Investigation82, 1853–1863.
19.
TakakuM., WadaY., JinnouchiK., TakeyaM., TakahashiK., UsudaH., NaitoM., KuriharaH., YazakiY., KumazawaY., OkimotoY., UmetaniM., NoguchiN., NikiE., HamakuboT. & KodamaT. (1999). An in vitro coculture model of transmigrant monocytes and foam cell formation. Arteriosclerosis, Thrombosis, & Vascular Biology19, 2330–2339.
20.
WadaY., SugiyamaA., KohroT., KobayashiM., TakeyaM., NaitoM. & KodamaT. (2000). In vitro model of atherosclerosis using coculture of arterial wall cells and macrophage. Yonsei Medical Journal41, 740–755.
21.
DorweilerB., TorzewskiM., DahmM., OchsenhirtV., LehrH.A., LacknerK.J. & VahlC.F. (2006). A novel in vitro model for the study of plaque development in atherosclerosis. Thrombosis & Haemostasis95, 182–189.
22.
DorweilerB., TorzewskiM., DahmM., KirkpatrickC.J., LacknerK.J. & VahlC.F. (2008). Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thrombosis & Haemostasis99, 373–381.
23.
CummingsI., GeorgeS., KelmJ., SchmidtD., EmmertM.Y., WeberB., ZündG., HoerstrupS.P. (2012). Tissue-engineered vascular graft remodeling in a growing lamb model: Expression of matrix metalloproteinases. European Journal of Cardiothoracic Surgery41, 167–172.
24.
HoerstrupS.P., CummingsI., LachatM., SchoenF.J., JenniR., LeschkaS., NeuenschwanderS., SchmidtD., MolA., GünterC., GössiM., GenoniM. & ZundG. (2006). Functional growth in tissue-engineered living, vascular grafts: Follow-up at 100 weeks in a large animal model. Circulation114, Suppl. 1, I159–I166.
